8 results
Approaches to Evaluating Kidney Disease in Patients with HIV Infection #Pathophys #Nephro #IM #HIV #CKD #AKI
Patients with HIV ... Pathophys #Nephro #IM ... #HIV #CKD #AKI ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Points #EBM #Neuro #IM ... Fremanezumab #Migraine #CGRP ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
Group #EBM #Neuro #IM ... Fremanezumab #Migraine #CGRP ... AdverseEvents #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Points #EBM #Neuro #IM ... Fremanezumab #Migraine #CGRP ... CalcitoninGeneRelatedPeptideAntibody #NEJM
A 48-year-old-man presented to the dermatology clinic with a whitish discoloration and hyperkeratosis of the first
#Clinical #IM #InfectiousDisease ... TrichophytonRubrum #HIV ... RapidProgression #NEJM
Immunosuppressive Strategies for the Prevention or Treatment of Acute GVHD. Panel A shows several classic immunosuppressive
protein kinase (MEK ... Pathophysiology #IM ... Immunosuppression #NEJM
#ICUCard
RENAL
GFR
90-131
mL/min
((140-age)*Wt)/(72*Cr)
Glomerular Filtration Rate (Cockcroft)
CI Cr
90-131
mL/min
(CrU * volume)/CrS
Creatinine Clearance
FENa
0.0-1.0
%
((U/P Na)/(U/P Cr))*100
Fractional Excretion of Na+
Na req
mEq
(125-Na)*0.6*Wt
Required Sodium
FE Urea
70 mmHg on 100% mask ... - 3 min) then, IV ... NS) Atenolol: IV ... or IM: 0.5-1.0mg ... x4 q15-30min) *IM
Evolution of Purpura Fulminans - On physical examination, he had small purpura on his legs (Panel
small purpura on his ... that spread to his ... Clinical #Derm #EM #IM ... Meningococcemia #NEJM